Day: June 3, 2025

VANCOUVER, British Columbia, June 03, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that shareholders voted in favour of all items of business at the Company’s 2025 Annual General Meeting (“AGM”) held on June 3, 2025 in Vancouver. A total of 137,600,042 votes were cast or represented by proxy at the AGM, representing 50.23% of the outstanding common shares as of the record date. The following is a tabulation of the votes submitted by proxy:DIRECTORS NUMBER OF SHARES PERCENTAGE OF VOTES CASTFOR WITHHELD/ ABSTAIN FOR WITHHELDRex J. McLennan 78,925,775 16,641,936 82.59% 17.41%Margaret M. Beck 94,445,855 1,121,856 98.83% 1.17%Daniel Dickson 94,821,211 746,500 99.22% 0.78%Amy Jacobsen 94,670,510 897,202 99.06% 0.94%Angela Johnson 93,733,044 1,834,668 98.08% 1.92%Kenneth...

Recently disclosed clinical cohort data from high (1×1015 total vg) and low dose (5.7×1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting alignment with FDA on primary endpoint in the pivotal Part B trial of TSHA-102 Previously disclosed preclinical data supporting broad biodistribution across brain and spinal cord regions following lumbar intrathecal delivery of AAV9 gene therapy vectors in non-human primates Symposium on Rett syndrome natural history data findings DALLAS, June 03, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases...

DALLAS, TX, June 03, 2025 (GLOBE NEWSWIRE) — Twin Hospitality Group Inc. (“Twin Hospitality”) (NASDAQ: TWNP), the parent company of Twin Peaks Restaurant, today announced that the Company will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, June 4, 2025 at 4:00 PM Eastern Standard Time. Scheduled 1×1 meetings with management are also available for registered, qualified investor attendees. Attendees interested in viewing the live presentation can register for this event, at no cost, here: Virtual Equity Conference Registration A video webcast of the presentation will be available following the event on the Company’s website https://twinpeaksrestaurant.com under the “Investors” section, and as part of a complete catalog of presentations available on Channelchek www.channelchek.com...

NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company’s chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations. About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse...

ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced its participation at the following investor conferences:June 12, 2025 – Lucas Harper, Chief Investment Officer, and Roland Austrup, Chief Growth Officer, will present at Sidoti’s Virtual Small Cap Conference. The presentation will begin at approximately 3:15 p.m. ET and will be webcast live, which can be accessed via Innventure’s Investor Relations website at https://ir.innventure.com/. Management will also be available for 1×1 and small group investor meetings. June 25, 2025 – Bill Haskell, Chief Executive Officer, will attend Northland’s Virtual Growth Conference and be available for 1×1 and small group investor meetings. June 25 and June 26, 2025 – Roland Austrup,...

CHANDLER, Ariz., June 03, 2025 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Bank of America 2025 Global Technology Conference on Wednesday, June 4, 2025 at 9:20 a.m. (Pacific Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by B of A, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC’s...

KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received a letter (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”) dated June 3, 2025, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). As previously announced, Cyclacel received a notification letter from Nasdaq dated December 6, 2024, indicating that its shares of common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of Nasdaq. According to the Compliance Notice,...